[Federal Register Volume 73, Number 154 (Friday, August 8, 2008)]
[Notices]
[Page 46299]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-18285]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Center for Preparedness, Detection, and Control of 
Infectious Diseases

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Clinical Laboratory Improvement Advisory Committee 
(CLIAC).
    Times and Dates: 8:30 a.m.-5 p.m., September 10, 2008; 8:30 
a.m.-3 p.m., September 11, 2008.
    Place: Centers for Disease Control and Prevention, 1600 Clifton 
Road, NE., Tom Harkin Global Communications Center, Building 19, 
Room 232, Auditorium B, Atlanta, Georgia 30333.
    New Information--Online Registration Required: In order to 
expedite security clearance process at the CDC Roybal Campus located 
on Clifton Road, all CLIAC attendees are required to register in 
advance for the meeting at http://www.cdc.gov/cliac/default.aspx by 
clicking the Register for a ``Meeting'' link and completing all 
forms according to the instructions given. Please complete all the 
required fields and submit your registration as far in advance of 
the meeting date as possible.

    Note: The cut-off date for registration for domestic attendees 
is Thursday, September 4, 2008; the cut-off date for international 
attendees to register is Monday, August 25, 2008.


    Status: Open to the public, limited only by the space available. 
The meeting Room accommodates approximately 100 people.
    Purpose: This Committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, CDC, 
regarding the need for, and the nature of, revisions to the 
standards under which clinical laboratories are regulated; the 
impact on medical and laboratory practice of proposed revisions to 
the standards; and the modification of the standards to accommodate 
technological advances.
    Matters to Be Discussed: The agenda will include updates from 
the CDC, the Centers for Medicare & Medicaid Services, and the Food 
and Drug Administration; a report from the CLIAC Workgroup on Good 
Laboratory Practices for Genetic Testing, and discussion of the 
Workgroup's proposals related to such; presentations and discussion 
related to laboratory quality control through risk management; and 
an introduction to the status of waived testing and discussion of 
the potential for waiver of automated hematology devices. Agenda 
items are subject to change as priorities dictate.
    Providing Oral or Written Comments: It is the policy of CLIAC to 
accept written public comments and provide a brief period for oral 
public comments whenever possible.
    Oral Comments: In general, each individual or group requesting 
to make an oral presentation will be limited to a total time of five 
minutes (unless otherwise indicated). Speakers must also submit 
their comments in writing for inclusion in the meeting's Summary 
Report. To assure adequate time is scheduled for public comments, 
individuals or groups planning to make an oral presentation should, 
when possible, notify the contact person below at least one week 
prior to the meeting date.
    Written Comments: For individuals or groups unable to attend the 
meeting, CLIAC accepts written comments until the date of the 
meeting (unless otherwise stated). However, the comments should be 
received at least one week prior to the meeting date so that the 
comments may be made available to the Committee for their 
consideration and public distribution. Written comments, one hard 
copy with original signature, should be provided to the contact 
person below. Written comments will be included in the meeting's 
Summary Report.
    Contact Person for Additional Information: Nancy Anderson, 
Chief, Laboratory Practice Standards Branch, Division of Laboratory 
Systems, National Center for Preparedness, Detection, and Control of 
Infectious Diseases, Coordinating Center for Infectious Diseases, 
CDC, 1600 Clifton Road, NE., Mailstop F-11, Atlanta, Georgia 30333; 
telephone (404) 498-2741; fax (404) 498-2219; or via e-mail at 
<a href="/cdn-cgi/l/email-protection#e4aa858a879dcaa58a808196978b8aa4878087ca8c8c97ca838b92"><span class="__cf_email__" data-cfemail="aee0cfc0cdd780efc0cacbdcddc1c0eecdcacd80c6c6dd80c9c1d8">[email protected]</span></a>.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for CDC and the Agency for Toxic Substances and Disease 
Registry.

    Dated: July 28, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E8-18285 Filed 8-7-08; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>